Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclic AMP-dependent protein kinase mediates a cyclic AMP-stimulated decrease in ornithine and S-adenosylmethionine

P A Insel, J Fenno

    Proceedings of the National Academy of Sciences of the United States of America
    |February 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cyclic AMP/PKA-promoted apoptosis: insights from studies of S49 lymphoma cells.

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2014
    Same author

    Role of phosphodiesterases in adult-onset pulmonary arterial hypertension.

    Handbook of experimental pharmacology·2011
    Same author

    GPCR expression in tissues and cells: are the optimal receptors being used as drug targets?

    British journal of pharmacology·2011
    Same author

    Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger.

    Acta physiologica (Oxford, England)·2011
    Same author

    G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains.

    Handbook of experimental pharmacology·2008
    Same author

    Do studies in caveolin-knockouts teach us about physiology and pharmacology or instead, the ways mice compensate for 'lost proteins'?

    British journal of pharmacology·2006

    N6,O2'-dibutyryl cyclic AMP (Bt2cAMP) reduces key polyamine synthesis enzymes in S49 cells, mediated by protein kinase. This mirrors cell cycle arrest, suggesting cell passage is crucial for enzyme activity.

    Area of Science:

    • Cell Biology
    • Biochemistry
    • Molecular Biology

    Background:

    • Polyamines are essential for cell growth and proliferation.
    • Ornithine decarboxylase and S-adenosylmethionine decarboxylase are key enzymes in polyamine synthesis.
    • Cyclic AMP (cAMP) signaling pathways regulate various cellular processes.

    Purpose of the Study:

    • To investigate the effect of N6,O2 -dibutyryl cyclic AMP (Bt2cAMP) on polyamine synthesis enzymes in S49 lymphoma cells.
    • To elucidate the role of cAMP-dependent protein kinase in regulating these enzymes.
    • To correlate enzyme activity changes with cell cycle progression.

    Main Methods:

    • Incubation of S49 cells with varying doses of Bt2cAMP.
    • Assay of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities.

    Related Experiment Videos

  • Studies using S49 mutant clones with altered protein kinase.
  • Analysis of cell cycle arrest and release dynamics.

    • Main Results:

    • Bt2cAMP dose-dependently decreased ornithine decarboxylase and S-adenosylmethionine decarboxylase activities after a 3-hr delay.
    • cAMP-dependent protein kinase was identified as the mediator of this decrease.
    • The enzyme activity decrease paralleled cAMP-stimulated G1 cell cycle arrest.
    • Ornithine decarboxylase activity decreased faster than Bt2cAMP-induced arrest and increased faster than G1 exit.

    Conclusions:

    • cAMP signaling, via protein kinase, downregulates key polyamine synthesis enzymes in S49 cells.
    • These effects are linked to cell cycle arrest, specifically in the G1 phase.
    • Cell cycle passage appears necessary for maintaining the activity of ornithine and S-adenosylmethionine decarboxylases, contrasting with other cell types.